百克瑞杀菌液治疗坏死性筋膜炎耐药菌株效果  

The clinical experience of Bactericide for treating necrotizing fascitis with drug-resistant chains

作　　者：周立群[1] 陈剑秋[1] 

机构地区：[1]天津医科大学第二医院,天津300211

出　　处：《天津药学》2007年第2期37-38,共2页Tianjin Pharmacy

摘　　要：目的:评价百克瑞杀菌液(Bacteric ide)治疗坏死性筋膜炎产生耐药菌株的临床效果。方法:坏死性筋膜炎出现耐药菌株(主要为金黄色葡萄球菌)患者18例,10例应用百克瑞杀菌液(A组)治疗;8例清创后应用常规方法处理创面(B组)。结果:A组患者绝大部分创面耐药菌株转阴,创面坏死组织液化脱落彻底,新生肉芽组织增生迅速,创面愈合时间缩短,疗效明显优于B组患者。结论:百克瑞是一种疗效高、作用强的外用杀菌药物,特别适用于产生耐药菌株筋膜组织坏死的临床治疗。OBJECT To evaluate the clinical experience of bactericide for treating necrotizing fascitis with drug - resistant chains. METHODES 10 patients treated with bactericide （ group A ） 8 patients treated by routine method （ group B ）. RESULT Most of the drug - resistant chains in group A change into negative. CONCLUSION Bactericide is a super - effective and most useful external medication, especially used in treating necrotizing fascitis with drugresistant chains.

关 键 词：百克瑞杀菌液坏死性筋膜炎耐药菌株 

分 类 号：R977.3[医药卫生—药品]